---
title: "Intensity Therapeutics (INTS.US) — 財務報表"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/INTS.US/norm.md"
symbol: "INTS.US"
name: "Intensity Therapeutics"
parent: "https://longbridge.com/zh-HK/quote/INTS.US.md"
datetime: "2026-03-14T03:29:50.265Z"
locales:
  - [en](https://longbridge.com/en/quote/INTS.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/INTS.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/INTS.US/norm.md)
---

> 支持的語言: [English](https://longbridge.com/en/quote/INTS.US/norm.md) | [简体中文](https://longbridge.com/zh-CN/quote/INTS.US/norm.md)


# Intensity Therapeutics (INTS.US) — 財務報表

## 損益表 (USD)

| 指標 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -1.55 | -3.36 | -5.51 | -5.52 | -6.36 |
| ROE | -227.17% | -806.04% | -823.37% | -446.69% | -345.94% |
| Revenue | - | - | - | - | - |
| Net income | -2.67M | -2.54M | -3.35M | -3.18M | -3.51M |
| Operating income | -2.73M | -2.71M | -3.39M | -3.20M | -3.57M |
| Gross margin | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| Profit quality | - | - | - | - | - |

## 資產負債表 (USD)

| 指標 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 9.59M | 4.44M | 3.06M | 4.78M | 5.21M |
| Leverage | 1.33 | 2.03 | 9.18 | 1.64 | 1.88 |
| BVPS | 3.68 | 2.09 | 0.5470 | 4.82 | 5.01 |
| Turnover | - | - | - | - | - |
| Cash & STI | 7.07M | 2.22M | 929000.00 | 2.59M | 2.78M |
| Inv & Rec | - | - | - | - | - |
| LT assets | 103000.00 | 109000.00 | 116000.00 | 122000.00 | 128000.00 |
| Net debt | -6.95M | -2.09M | -798000.00 | -2.45M | -2.64M |

## 現金流量表 (USD)

| 指標 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -2.39M | -2.46M | -1.99M | -2.67M | -3.97M |
| Investing CF | - | - | - | 0.0000 | 3.10M |
| Financing CF | 7.24M | 3.74M | 328000.00 | 2.48M | 413000.00 |
| Free CF | -1.42M | -1.61M | -762250.00 | -1.46M | -2.53M |
| OCF coverage | - | - | - | - | - |
| Repaid & issued | - | - | - | - | - |
| CapEx | - | - | - | - | - |